Doctors.am

Narina K. Sargsyants

My consultations
Infectionist
Hepatologist
Speciality

Health Ministry Advisor in the field of Infectious Diseases

Infectologist at Elit-Med Medical Center

Hepatologist at Medecins sans frontiers (MSF) France in Armenia

Infectologist in Nor-Arabkir Medical Center

Member of «World Journal of Hepatology» editorial board

Position
3/15 Hakob Hakobyan st., Yerevan, Armenia
Address
+374 91 57 98 45
+374 10 22 33 23
Phone
Question to doctor

Scientific Degree

MD, PhD

Education

1990-1996
Yerevan State Medical University, Faculty of General Medicine
1996-1999
Yerevan State Medical University, Residency, speciality – Infectious diseases
2004-2009
Yerevan State Medical University, PhD research, topic: “Clinical, epidemiological peculiarities and results of treatment with Pegylated interferon-alpha 2a and Ribavirin of chronic viral hepatitis C in Armenia”

Trainings

2014
Department of Gastroenterology/Hepatology at the Medical University – General hospital Vienna (AKH), Austria, sponsored by The American Austrian Foundation, The Soros Foundation and Austrian Ministry of Science and Research, March 3 – 28, (Supervisor - Prof Peter Ferenci)
2014
Department of Division of Gastroenterology, Hepatology, Nephrology and Diabetology at the Medical University Hospital – Salzburger Landeskliniken (SALK), Austria, sponsored by The American Austrian Foundation, The Soros Foundation and Austrian Ministry of Science and Research, April 1 – 25, (Supervisor - Dr Michael Strasser)
2011
Università Cattolica, Rome, Italy, sponsored by European Society of Clinical Microbiology and Infectious Diseases (ESCMID), October 27 th to November 4th, (Supervisor - Prof Roberto Cauda)
2010
Department of Infectious Diseases and tropical medicine at the Medical University - General hospital Vienna (AKH), Austria, sponsored by The American Austrian Foundation, The Soros Foundation and Austrian Ministry of Science and Research from September 7 –30, (Supervisor - Prof Wolfgang Graninger)
2010
Hospital Universitario Virgen Macarena, Sevilla, Spain, sponsored by European Society of Clinical Microbiology and Infectious Diseases (ESCMID), April 21th to April 30th, (Supervisor - Prof Jesús Rodríguez-Baño)
2008
MEDICAL EXCHANGE PROGRAMME FOR YOUNG HIV PHYSICIANS in CHU de Bicêtre, Paris, sponsored by European AIDS Clinical Society (EACS), July 15 th to August 25th (Supervisor - Prof Jean François Delfraissy)

Images

Publications

135 (53 in English), include 13 in Russian and 71 in international publications, 33 abstracts and/or posters in international conferences
EDITORIAL BOARD: «World Journal of Hepatology»

Scientific works

POSTER PRESENTATION
2018
Hepatitis C and multidrug resistant tuberculosis co-morbidities: no longer an untreatable combination, Poster Presentation at Médecins Sans Frontières (MSF) Scientific Day, May 15, 2018, https://doi.org/10.7490/f1000research.1115465.1
2018
HYPERFERRITINEMIA IN PATIENTS WITH CHRONIC LIVER DISEASES, Poster Presentation (CC-04-099) abstract at the 27th Conference of the APASL, March 14th-18th, New Delhi, India
2018
DYNAMIC OF CLINICAL AND LABORATORY ABNORMALITIES IN SMALL COHORT OF HCV-INFECTED PATIENTS TREATED WITH SOFOSBUVIR CONTAIN REGIMENS, Poster Presentation (CC-04-059) abstract at the 27th Conference of the APASL, March 14th-18th, New Delhi, India
2018
CLINICAL AND VIROLOGICAL RESPONSE ON INDIAN GENERIC OF DAA REGIMENS WITH/WITHOUT IFN IN HCV-INFECTED PATIENTS, REAL WORLD DATA, Poster Presentation (CC-04-058) abstract at the 27th Conference of the APASL, March 14th-18th, New Delhi, India
2018
BIOCHEMICAL PARAMETERS ABNORMALITIES IN EBV-ASSOCIATED INFECTIOUS MONONUCLEOSIS, Poster Presentation (CC-01-051) abstract at the 27th Conference of the APASL, March 14th-18th, New Delhi, India
2018
Description of the Course and Outcomes of Antiviral Treatment of 1000 HCV Infected Patients, Poster Presentation, abstract at the 27th Conference of the APASL, March 14th-18th, New Delhi, India
2017
Real world data concerning rapid virological response and tolerability of DAAs with/without IFN regimens in small cohort of HCV-infected patients, 13th International Workshop on Co-infection: HIV & Hepatitis, on 21 - 23 June, Lisbon, Portugal
2017
Nosocomial outbreak of HCV-infection, Poster Presentation (PP1878) abstract SA-APASL2017-25497 at the 26th Conference of the APASL, Shanghai, China, 15th -19th February
2017
Result of short questionary concerning guidelines on management of HBV-infection among Armenian physicians, Poster Presentation (PP0791) abstract SA-APASL2017-25577 at the 26th Conference of the APASL, Shanghai, China, 15th -19th February
2017
Outcomes of Severe Complications in Patient with Decompensated HCV-associated Cirrhosis with SVR after Treatment with Sofosbuvir/Ledipasvir, Poster Presentation (PP1893) abstract SA-APASL2017-27938 at the 26th Conference of the APASL, Shanghai, China, 15th -19th February
2016
Success in difficult-to-treat patient with НСV-associated glomerulonephritis, Poster Presentation abstract 10110 at the 25th Conference of the APASL, Tokyo, Japan, February 20-24
2015
Influence of predictor variables on FibroMax results, Abstract/ePoster RS-2771 at the European Association for the Study of the Liver the 50th International Liver Congress (ILC), Vienna, Austria, April 22- 26, Hepatology, Vol.62, S 736-737
2015
Prognostic value of hyperferritinemia in patients with chronic hepatitis C, Poster Presentation POS-C4 at APASL STC on HCV, 18-20 December, New Delhi, India, Poster of Distinction
2015
Comparison of HCV genotyping distribution in Armenia during ten years, Abstract, Poster Presentation at the 22nd International Symposium on Hepatitis C Virus and Related Viruses meeting, Strasbourg, France, October 9-13
2014
Influence of predictor variables on degree of fibrosis in chronic НВV-infection measured by Fibrotest, Poster P73, EASL/APASL Special Conference on the Optimal Management of Hepatitis B Virus Infection in Athens, September 25-27
2013
INFLUENCE OF PREDICTOR VARIABLES ON QUALITY OF LIFE PATIENTS WITH CHRONIC VIRAL HEPATITIS C, Poster Presentation abstract A-533-0021-00223 at the 48th annual meeting of the European Association for the Study of the Liver, The Netherlands, April 24-28
2013
The experience of granulocyte colonystimulating factor administration for neutropenia correction in IFN-experienced patient with HCV-associated liver cirrhosis treated with Peg-IFN alpha 2a plus Ribavirin, Poster Presentation abstract A-535-0018-02382 at the 23rd Conference of the APASL, Singapore, 6-10 June
2013
Gammaglutamyltransferase in patient with chronic hepatitis C during the treatment with PEG Interferon Alfa 2a with ribavirin, 2nd Biannual Inter¬national Conference of Armenian Hepatological Forum, Yerevan September 6-7
2013
Results of IL-28B gene polymorphism in patients with chronic НCV-infection in Armenia, 2nd Biannual Inter¬national Conference of Armenian Hepatological Forum, Yerevan September 6-7
2013
Some results of GenoFibroTest in patients with chronic НСV-infection, 2nd Biannual Inter¬national Conference of Armenian Hepatological Forum, Yerevan September 6-7
2012
Immunoglobulins concentration in HIV-infected patients' with viral hepatitis, candidiasis and herpes simplex viral infection, International Symposium on HIV & Emerging Infectious Diseases, France, Marseille, 23-25 May Abstract-No:1215
2012
Predictor variables of efficacy the treatment with PEG Interferon Alfa 2a plus ribavirin in chronic hepatitis C, 14th International Symposium on Viral Hepatitis and liver Disease (ISVHLD), China, Shanghai 22-25 June
2011
Interrelationship of immune surrogate markers in HIV-infected patients, The 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Rome 17-20 July, abstract CD-ROM, Abstract-No: A-361-0035-03722
2011
Immune surrogate markers in HIV-infected patients' with viral hepatitis, candidiasis and herpes simplex viral infection, The 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Rome 17-20 July, abstract CD-ROM, Abstract-No: A-361-0034-03805
2011
Biphasic thyroid dysfunction in patient with chronic hepatitis C treated with interferon-alpha and ribavirin, Poster Presentation abstract A-315-0024-01825 at the 21th Conference of the APASL, 17-20 February 2011, QSNCC, Bangkok Thailand
2011
Analysis of ferritinemia level in patients with chronic hepatitis C, 17th Russian Gastroenterology Weak, oral presentation
2010
Severe case of pneumocystis pneumonia in HIV-patient due to IRIS, Poster Presentation at 25th IUSTI Europe Conference
2010
Clinical aspects of chronic HCV-infection in Armenia, Poster Presentation at The 3rd International Tehran Hepatitis Congress
2010
Epidemiology of viral hepatitis C in Armenia, Poster Presentation at The 3rd International Tehran Hepatitis Congress
2010
Influence of predictor variables on side effects of the treatment with PEG interferon Alfa 2a plus ribavirin in chronic hepatitis C, Poster Presentation No.: P-144 at 4th Ditan International Conference on Infectious Diseases (DICID), International Journal of Infectious Diseases Abstract No. SA00360 (Prize Winner)
2010
Comparison of liver function tests in responders and non-responders of the treatment with PEG Interferon Alfa 2a plus ribavirin in chronic hepatitis C, Poster Presentation No.: PP-324 at the 20th Conference of the APASL, 25 – 28 March, Beijing, China
2008
Soluble Markers of Immune Activation in HIV/HCV Co-infection, 15th International Symposium on HIV & Emerging Infectious Diseases, France, Toulon, p. 2

Memberships

“European association for the study of the liver” (EASL)
“European Society of Clinical Microbiology and Infectious Diseases” (ESCMID)
“International Society for Infectious Diseases” (ISID)
“Armenian Association for the Study of the Liver” (ARASL)
“Armenian evidence-based medicine society”

Question to doctor

Dear visitor, here you can contact with a doctor by e-mail. Please note that the site administration is not responsible for further communication or any information provided by your doctor.:

    Files should not exceed 2MB .

    The types of allowed files are png, gif, jpg, jpeg.